Literature DB >> 9425320

The role of osteopontin in tumorigenesis and metastasis.

A J Oates1, R Barraclough, P S Rudland.   

Abstract

Osteopontin (OPN) is a calcium-binding phosphoprotein which is believed to play a role in several different and apparently distinct cellular processes. Recently, expression of OPN has been linked to tumorigenesis and metastasis in several experimental animal models and human patient studies. Precisely what role OPN plays in these processes is far from clear. OPN is known to importantly contribute to cell adhesion interactions, possibly mediated by the highly conserved GRGDS amino acid sequence, a motif found on a number of proteins which play a role in cell adhesion. In addition, OPN has binding affinity for several different cellular receptors, potentially allowing it to stimulate various signaling pathways and influence distinct cellular events which may ultimately favor tumorigenesis or metastasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9425320

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  34 in total

1.  Human mesenchymal stem cell and epithelial hepatic carcinoma cell lines in admixture: concurrent stimulation of cancer-associated fibroblasts and epithelial-to-mesenchymal transition markers.

Authors:  Syamal D Bhattacharya; Zhiyong Mi; Lindsay J Talbot; Hongtao Guo; Paul C Kuo
Journal:  Surgery       Date:  2012-09       Impact factor: 3.982

2.  Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines.

Authors:  Syamal D Bhattacharya; Juline Garrison; Hongtao Guo; Zhiyong Mi; Jovan Markovic; Victoria M Kim; Paul C Kuo
Journal:  Surgery       Date:  2010-06-23       Impact factor: 3.982

3.  Expression of bone sialoprotein and osteopontin in breast cancer bone metastases.

Authors:  T Ibrahim; I Leong; O Sanchez-Sweatman; R Khokha; J Sodek; H C Tenenbaum; B Ganss; S Cheifetz
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea.

Authors:  Taichang Jang; Todd Savarese; Hoi Pang Low; Sunchin Kim; Hannes Vogel; David Lapointe; Timothy Duong; N Scott Litofsky; James M Weimann; Alonzo H Ross; Lawrence Recht
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

5.  Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH.

Authors:  Jin-Cai Wu; Bing-Sheng Sun; Ning Ren; Qing-Hai Ye; Lun-Xiu Qin
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-16       Impact factor: 4.553

6.  Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.

Authors:  Wang Likui; Wang Hong; Zhang Shuwen
Journal:  J Gastrointest Surg       Date:  2009-09-18       Impact factor: 3.452

7.  Osteopontin Expression in Patients with Hepatolith.

Authors:  Bum Soo Kim; Sun Hyung Joo; Sung Jig Lim; Kwang Ro Joo
Journal:  Indian J Surg       Date:  2013-05-18       Impact factor: 0.656

8.  Inhibition of hydroxyapatite formation by osteopontin phosphopeptides.

Authors:  David A Pampena; Karen A Robertson; Olga Litvinova; Gilles Lajoie; Harvey A Goldberg; Graeme K Hunter
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

9.  Osteopontin expression in squamous cell cancer of the esophagus.

Authors:  I-Chen Wu; Ming-Tsang Wu; Shah-Hwa Chou; Sheau-Fang Yang; Yih-Gang Goan; Jang-Ming Lee; Yi-Pin Chou; Ming-Jong Bair; Tsang-En Wang; Angela Chen; Wen-Hsiung Chang; Fu-Chen Kuo; Deng-Chyang Wu
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

10.  Biomolecular markers in cancer of the tongue.

Authors:  Daris Ferrari; Carla Codecà; Jessica Fiore; Laura Moneghini; Silvano Bosari; Paolo Foa
Journal:  J Oncol       Date:  2009-08-19       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.